Announced details
Acute ischemic stroke treatment; medical care and pharmaceutical development
The Company’s Chairman of the Board, Hasumi Keiji (蓮見惠司), will appear on the program and explain the SMTP compounds.
A program that presents Japan’s cutting-edge medical care and themes related to health and daily life to audiences worldwide.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | SMTP compound family, TMS-007(JX10), TMS-008 |
| Counterparty | NHK WORLD JAPAN「Medical Frontiers」 |
| Counterparty overview | A program that presents Japan’s cutting-edge medical care and themes related to health and daily life to audiences worldwide. |
| Relationship with the Company | The Company’s Chairman of the Board, Hasumi Keiji (蓮見惠司), will appear on the program and explain the SMTP compounds. |
| Launch date | 23 November 2026 (scheduled; start of live streaming). Available on demand after broadcast. |
| Applicable area | Acute ischemic stroke treatment; medical care and pharmaceutical development |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because NHK WORLD JAPAN’s “Medical Frontiers” is a program that presents Japan’s cutting-edge medical care and themes related to health and daily life to audiences worldwide.